{"id":"W4220978609","doi":"10.1016/j.jaip.2022.02.047","title":"Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America","year":2022,"lang":"en","type":"article","venue":"The Journal of Allergy and Clinical Immunology In Practice","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Saskatchewan; University of Calgary","funders":"Sanofi Genzyme; Genentech; Covis Pharma; Amgen; Boehringer Ingelheim; AstraZeneca; Chiesi Farmaceutici; Meso Scale Diagnostics; Sanofi; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Novartis; GlaxoSmithKline","keywords":"Medicine; Rate ratio; Asthma; Demography; Incidence (geometry); Concomitant; Population; Observational study; Medical prescription; Family medicine; Internal medicine; Pediatrics; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003343825,0.000316836,0.000672932,0.001477245,0.0005329623,0.001646001,0.0006086561,0.0006067684,0.002481188],"category_scores_gemma":[0.005158257,0.000227336,0.002181249,0.002387604,0.0005324376,0.000732576,0.001462939,0.0006539723,0.0003293737],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004248994,"about_ca_system_score_gemma":0.0008968278,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02207958,"about_ca_topic_score_gemma":0.02570181,"domain_scores_codex":[0.9981017,0.0005492842,0.0002473547,0.0006336606,0.0002649049,0.0002032102],"domain_scores_gemma":[0.9934074,0.001781365,0.002639676,0.0006335867,0.0009347348,0.0006033573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003559559,0.00002720288,0.9853497,0.0001951619,0.001317577,0.0001186545,0.0005255725,0.00008612421,0.0002354511,0.0002467626,0.001377835,0.01016407],"study_design_scores_gemma":[0.00001364711,0.00003229111,0.9956263,0.0001985326,0.0004553744,0.0001914524,0.0004649639,0.00006011484,0.00004069094,0.00008420247,0.002825227,0.000006971472],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9537752,0.03135184,0.0005290038,0.001857149,0.0001482353,0.00002318416,0.003412244,0.00001638122,0.008886863],"genre_scores_gemma":[0.9916154,0.004484339,0.0002167618,0.0009334086,0.0001553964,0.00001720212,0.002170035,0.00001861673,0.0003888463],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02207958,"threshold_uncertainty_score":0.04390216,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02860247901186177,"score_gpt":0.3205655994398333,"score_spread":0.2919631204279716,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}